Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.

@article{Berres2011SerumCC,
  title={Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.},
  author={M E Berres and Francisco Javier Cubero and Maximilian Schmeding and Dennis Eurich and Frank Tacke and Marcus Bahra and Peter Neuhaus and Ulf Peter Neumann and Hermann Elard Wasmuth},
  journal={Hepatology},
  year={2011},
  volume={53 2},
  pages={596-603}
}
UNLABELLED The recurrence of liver fibrosis after liver transplantation (LT) for hepatitis C virus (HCV) infection is responsible for graft loss and patient mortality. Although the contribution of the immune system to fibrosis recurrence is anticipated, systematic studies evaluating immune parameters as predictive markers of allograft fibrosis are lacking. The infiltration of immune cells into the graft is governed by chemokines. Here we assessed the predictive value of serum levels of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 39 references

The CXC chemokine ligand 4 (CXCL4) is a platelet-derived mediator of experimental liver fibrosis

  • MM Zaldivar, K Pauels, P von Hundelshausen, ML Berres, P Schmitz, J Bornemann
  • HEPATOLOGY
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…